Isosceles Pharmaceuticals
Mark Mannebach has over 30 years of experience in the pharmaceutical industry in Regulatory Affairs with extensive knowledge of Quality Assurance, Program Management, and Pharmaceutical Science. During his career, he has filed numerous NDA’s, BLA’s, PME’s, ANDA’s and 505(b)(2) submissions. Mark has assisted with the development of branded and specialty pharmaceuticals as well as biologics for many therapeutic applications including ophthalmology, pain management, neurology/CNS, and anti-inflammation.
This person is not in any teams
This person is not in any offices
Isosceles Pharmaceuticals
Isosceles Pharmaceuticals is an preclinical stage biotech developing a perioperative acute pain product candidates using actives with an approved drug master file and an excellent safety profile.